User banner image
User avatar
  • admin

Posts

Totus Medicines Presents Early Phase 1b Clinical Data Demonstrating 100% Disease Control Rate and Class-Leading Safety for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER2- Breast Cancer at ESMO Breast Cancer Annual Congress 2026

TOS-358 is a covalent, pan-mutant, a-selective PI3K inhibitor designed to address key limitations of existing PI3Ka therapies which include limited mutation coverage and poor tolerability First...

Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer

Data contributed to the scientific and clinical rationale for RASolute 302, a pivotal Phase 3 trial in second line treatment of patients with metastatic pancreatic...

Flaminia Romani Expands Industry Footprint with Key Guild Memberships and New Productions in Development

Sydney, Australia, May 06, 2026 (GLOBE NEWSWIRE) — Australian film director Flaminia Romani has entered a new phase of professional growth following her recent association with...

Amid Rising Microplastic and Toxic Skincare Concerns, Vexivo Launches Fully Organic, Hexane-Free Castor Oil Roll-On

Clean beauty is no longer a niche preference. It is becoming the new standard. Smyrna, DE, May 06, 2026 (GLOBE NEWSWIRE) — Microplastics in skincare...

Loblaw Companies Limited Announces Normal Course Issuer Bid

BRAMPTON, Ontario, May 06, 2026 (GLOBE NEWSWIRE) — (TSX: L) – Loblaw Companies Limited (Loblaw) announced today that the Toronto Stock Exchange (TSX) has accepted...

Amaze Announces Partnership with All Media Solutions to Power Brand Supply for Amaze Live

Partnership unlocks immediate access to brand inventory, enabling monetization at launch of Amaze Live on May 15 NEWPORT BEACH, Calif., May 06, 2026 (GLOBE NEWSWIRE)...

Loblaw Reports First Quarter Revenue Growth of 4.2% and Adjusted Diluted Net Earnings Per Common Share Growth of 10.6%

BRAMPTON, Ontario, May 06, 2026 (GLOBE NEWSWIRE) — Loblaw Companies Limited (TSX: L) (“Loblaw” or the “Company”) announced today its unaudited financial results for the...

dsm-firmenich Q1 2026 trading update

Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), May 6, 2026 dsm-firmenich Q1 2026 trading updateSolid start to the year driven by good LFL sales growth Highlights 4%...

ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors

Dr. Doody joins from Senior Leadership in Neurodegeneration at F. Hoffman-LaRoche LTD and biotech Axxium Life ATLANTA and BOSTON, May 06, 2026 (GLOBE NEWSWIRE) —...

Annexon to Present at the Bank of America Securities Health Care Conference 2026

BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at...